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ABSTRACT
Manda Koso is a commercial fermented plant product (FPP) made from 53 types of fruits and 
vegetables that are fermented for more than 3 years.  We hypothesized that the FPP can prevent 
infection by influenza virus and human norovirus.  Therefore, we investigated the effects of the 
FPP on influenza virus and feline calicivirus, a surrogate of human norovirus.  We found that 
10% FPP inactivated the influenza virus but not the feline calicivirus.  Inhibition of the influenza 
virus was highly concentration-dependent: 1% and 0.3% FPP showed reduced inactivation effica-
cy.  The effects of the FPP on the influenza virus-infected cells were investigated by addition of 
the FPP to the culture medium after virus infection.  No suppressive effect of the FPP on influ-
enza replication in MDCK cells was observed.  The results showed that the FPP could inactivate 
influenza virus by affecting the virus particles.
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ABBREVIATIONS
DMEM  Dulbecco’s modified Eagle’s minimum 
essential medium
FPP fermented plant product
HAU haemagglutinating unit
LDH lactate dehydrogenase
MOI multiplicity of infection
MTT  3-(4,5-di-methylthiazol-2-yl)-2,5-diphen-
yltetrazolium bromide
PBS phosphate-buffered saline
TCID50 50% tissue culture infectious dose
The influenza virus (IFV), which belongs to the family 
Orthomyxoviridae, is a pathogen that causes respiratory 
infection.  Outbreaks of IFV infection occur every year 
and sometimes cause fatal diseases such as pneumonia, 
secondary bacterial pneumonia, and encephalopathy12). 
The human norovirus, which belongs to the family Cali-
civiridae, is a causative agent of epidemic gastroenteritis 
and is the most probable cause of food poisoning in Ja-
pan6).  It is difficult to study the human norovirus be-
cause it does not replicate in cultured cells or animals 
other than humans.  Closely related viruses such as the 
feline calicivirus (FCV) and mouse norovirus are used as 
surrogate viruses for scientific research.
Manda Koso is a fermented plant product (FPP) made 
of naturally fermented fruits, plant roots, cereals, marine 
algae, and kokuto, a type of cane sugar.  The raw ingredi-
ents are crushed and fermented by Lactobacillus spp.  and 
yeast generated spontaneously from the raw materials at 
room temperature for 3 years or more.  Manda Koso is a 
well-known natural health food that is consumed in Japan. 
The FPP is a slightly sweet, black-brown paste composed of 
36.9% water, 2.4% proteins and amino acids, 3.7% dietary 
fibres, 55.2% carbohydrates, and 1.8% ash13).  Consumption 
of Manda Koso has been reported to reduce fat content 
without affecting bone weight in ovariectomized rats9).  The 
FPP also exhibits free radical scavenging activity2).  Con-
sumption of Manda Koso by fish decreased thiobarbituric 
acid reactive substances in their tissues3).  In addition, in-
take of the FPP has been recently suggested to improve feed 
efficiency and intestinal histological status in broilers5).
We have reported that plant-derived tannins such as per-
simmon and green tea tannins efficiently inactivate human 
and avian IFVs 11).  IFV particles are aggregated by the tan-
nins and lose infectivity.  Resveratrol, a plant-derived poly-
phenol, and Cinnamomi cortex, a crude drug used in oriental 
Kampo medicines, have been reported to suppress IFV rep-
lication in MDCK cells by affecting the infected cells4,8). 
Because Manda Koso is derived from plants, we expected it 
to have an effect on IFV or human norovirus.  In this study, 
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FPP.  A part of the culture medium was collected 
at 1 hr (just after virus adsorption), 12 hr, and 24 
hr.  The haemagglutinating units (HAUs) in the 
samples were measured using chicken erythro-
cytes, and infectious titres (infectivities) were 
measured using the standard TCID50 method with 
MDCK(+) cells.  In separate experiments, MDCK 
cells were infected with IFV at an input MOI of 5.
Lactate dehydrogenase assay
MDCK cells were incubated in DMEM contain-
ing 10%, 5%, 2.5%, 1.3%, 0.6%, 0.3%, or 0.2% FPP 
for 24 hr, and the released lactate dehydrogenase 
(LDH) was measured using a colorimetric method 
with the Cytotoxicity LDH Assay Kit-WST (Dojin-
do Molecular Technologies, Inc, Kumamoto, Japan) 
and the plate reader TriStar LB941 (Bertohold 
Technologies, Wildbad, Germany) with absorbance 
at 485 nm.  The LDH value was set to 100% after 
NP-40 treatment, and the relative ratio of each 
sample was calculated.
MTT assay
The FPP was subjected to cytotoxicity assays by 
using Cell Proliferation Kit I (Roche Diagnostics, 
Basel, Switzerland), according to the manufactur-
er’s instructions.  Briefly, confluent MDCK cells in 
a 96-well plate were exposed to 100 μl/well of 
DMEM containing various concentrations of the 
FPP for 24 hr in a CO2 incubator.  Then, 10 μl of 
3-(4,5-di-methylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) was added, and the cells were fur-
ther incubated for 4 hr.  The cells were solubilized, 
and optical absorbance at 570 nm was measured 
using a microtiter plate reader (Model 680; Bio-Rad 
Laboratories, Hercules, CA).  Cell viability was esti-
mated by comparing the values of the FPP samples 
with that of DMEM without FPP.
RESULTS
Effects of the FPP on viruses
To investigate the effects of the FPP on virus 
particles, the FPP was incubated with IFV for 3 
min, and infectivity after the treatment was mea-
sured.  The FPP at 10% and 3% almost completely 
inactivated IFV, and at 1% and 0.3%, partly inac-
tivated IFV in a dose-dependent fashion (Fig. 1A). 
Prior filtration through a 0.22 µm filter weakened 
the inactivation (Fig. 1B), indicating that some 
type of large aggregates may be involved in the 
IFV inactivation. 
Inactivation of FCV, a surrogate of human noro-
virus, was also investigated.  The FPP had no ef-
fect on FCV, even at a high concentration of 10% 
(Fig. 1C).  The FCV stock contained abundant 
host cell proteins because the stock had been pre-
pared from infected cell lysates.  We speculated 
that such proteins or other ingredients may have 
weakened the inactivation activity of the FPP. 
we investigated the effects of the FPP on IFV and FCV.
MATERIALS AND METHODS
Reagents
The FPP, Manda Koso, was obtained from Manda Fer-
mentation Co., Ltd., Onomichi, Japan.  It is a black paste-
like material that is rich in nutrients such as carbohydrates, 
sugars, amino acids, and vitamins, as reported previously13). 
The FPP was dissolved in DMEM and frozen until use.
Cells and viruses
The MDCK(+) cells, which are canine kidney-derived 
cells7), were originally purchased from Sumitomo Daini-
ppon Pharma (Osaka, Japan), and CRFK cells, which are fe-
line kidney-derived cells, were purchased from ATCC and 
were propagated in Dulbecco’s modified minimum essential 
medium (DMEM; Wako Chemicals) supplemented with 
10% foetal calf serum, penicillin G (100 units/ml; Meiji 
Seika Pharma, Tokyo, Japan), and streptomycin (100 µg/ml; 
Meiji Seika Pharma).  Human IFV A/Udorn/72 (H3N2) was 
propagated in embryonated chicken eggs11).  The FCV F9 
strain, purchased from ATCC, was propagated in the CRFK 
cells.
Assay for inactivation of virus particles
The anti-viral assays for IFV and FCV were 
performed using the standard TCID50 method, as 
described previously [11].  In brief, 90 μl of the 
FPP solution and 10 μl of the virus solution were 
mixed and incubated for 3 min at room tempera-
ture.  The solution was then 10-fold serially dilut-
ed with DMEM. MDCK(+) cells or CRFK cells in 
a 96-well plate were inoculated with 50 μl of the 
diluted virus solution in quadruplicate or octupli-
cate.  After 1 hr of adsorption, the inoculum was 
removed, and the cells were incubated in 100 μl/
well of DMEM.  When the cytopathic effects had 
fully developed after several days, the cells were 
fixed with ethanol and acetate (5:1) and further 
stained with 0.5% amido black 10B in 45% ethanol 
and 10% acetate.  The 50% endpoint of the viral 
infection was determined using the Behrens–Kar-
ber method, and 50% tissue culture infectious dose 
(TCID50) was calculated.  Water was used instead 
of the FPP solution, and the infectivity was used 
as the virus infectivity of a mock-treated control. 
The anti-viral effects were estimated by comparing 
the FPP-treated infectivity with the mock-treated 
infectivity.
Assay of the effects of the FPP on the infected 
cells
MDCK cells were inoculated with IFV at an in-
put multiplicity of infection (MOI) of 0.2 and 
maintained for 1 hr in a CO2 incubator with occa-
sional tilting.  After adsorption, the inoculum was 
removed, and the cells were washed once with 
phosphate-buffered saline (PBS) and maintained 
in DMEM containing various concentrations of the 
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Figure 1. Effects of the FPP on pathogenic virus particles.  (A) The FPP at different concentrations was incubated with IFV for 3 
min.  The remaining infectivity was determined using the TCID50 method.  Experiments were repeated three times, and the average 
values are shown in the bar graph.  Error bars indicate standard deviation.  (B) Anti-IFV assays were performed for 10% FPP with 
or without filtration with a 0.22 µm filter as pre-treatment.  (C) Anti-FCV assays were performed for the FPP at different 
concentrations.  (D) FCV was diluted 10 times with PBS to eliminate the effects of cellular proteins and was used for an anti-virus 
assay (10%*, water*).
Figure 2. Effects of the FPP on influenza virus (IFV)-infected cells.  MDCK cells were infected with IFV at an input MOI of 0.2 and 
maintained for 1 hr in a CO2 incubator.  Then, the cells were incubated in DMEM containing the FPP at different concentrations 
and trypsin.  The culture medium was harvested at 1 hr, 12 hr, and 24 hr post infection, and HA (A) and infectivity (B) were 
measured.  (C) MDCK cells were infected with IFV at an MOI of 5, and HA activity in the culture medium was measured.  The 
average values are shown in the bar graph, and the error bars indicate standard deviation.
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the culture medium was suppressed.  Virus infec-
tivity in the samples also indicated inhibition of 
virus growth, especially in the case of treatment 
with 10% FPP (Fig. 2B).
When the cells were infected with the virus at 
an input MOI of 0.2, transmission of the virus to 
neighbouring cells and virus replication in the in-
fected cells were investigated.  To determine the 
reason for the inhibition, we performed a similar 
experiment after IFV infection at an MOI of 5. 
Under this condition, all the cells were infected si-
multaneously, and only virus replication in infected 
cells was evaluated.  Ten percent FPP did not 
strongly inhibit IFV replication (Fig. 2C), indicat-
ing that the one-step replication in the infected 
cells was not affected.  Thus, the FPP did not in-
hibit virus multiplication in the infected cells, but 
it inhibited transmission of the virus to neighbour-
ing cells.  This result is consistent with the finding 
that the FPP can inactivate IFV particles.
Cytotoxicity of the FPP to MDCK cells
We examined the cytotoxicity of the FPP to ex-
amine the mechanism underlying the inhibition of 
IFV replication.  MDCK cells were incubated with 
the FPP at different concentrations for 24 hr, and 
LDH level in the culture supernatant was measured 
(Fig. 3A).  Ten percent FPP caused an approximate-
ly 20% increase in LDH, suggesting disturbance of 
cell membrane integrity.  The MTT assay was also 
performed; in the presence of 10% FPP, MTT stain-
ing decreased to approximately 50% (Fig. 3B). 
These results indicate that 10% FPP caused consid-
erable cytotoxicity.  However, in the presence of 5% 
FPP or less, almost no cytotoxicity was observed.
DISCUSSION
In the present study, we showed that the FPP 
could inactivate virus particles of IFV but not 
those of FCV.  The FPP inhibited IFV replication 
in MDCK cells in low MOI experiments.  Thus, the 
FPP may affect the infected cells to disturb virus 
growth.  However, the results showed that the in-
hibition was due to the inhibition of IFV transmis-
sion from cell to cell, and not due to the inhibition 
of virus replication in the infected cells.  The 
mechanism underlying the inactivation of IFV 
particles is unknown; however, our results suggest 
that the mechanism underlying the inhibition was 
not virus-particle aggregation by the tannins of 
the FPP, as shown by persimmon or green tannins, 
because FCV was resistant to the FPP10,11).
It is also unclear why IFV, but not FCV, was inactivated. 
Detergents are known to inactivate envelope viruses such 
as IFV by impairing the lipid envelope encasing the viral 
genes.  In contrast, detergents are generally not effective 
in inactivating non-envelope viruses such as FCV.  Thus, 
there is a possibility that the FPP acted as a detergent; 
however, the FPP is not reported to have any detergent ac-
Thus, we diluted FCV 10-fold with PBS and mixed 
it with 10% FPP, and we then investigated the an-
ti-viral activity.  However, we observed no differ-
ence in virus inactivation between 10% FPP and 
water (Fig. 1D).  These results indicate that the 
FPP can inactivate IFV but not FCV.
Effects of the FPP on infected cells
To investigate the effects of the FPP on virus-
infected cells, MDCK cells were infected with IFV 
at an input MOI of 0.2, and the FPP was added to 
the maintenance medium.  The culture medium 
was harvested at 1 hr, 12 hr, and 24 hr post infec-
tion, and HAUs in the samples were measured. 
The HAUs were lower in the samples treated with 
5% and 10% FPP at 12 hr and 24 hr post infection 
(Fig. 2A), indicating that virus accumulation in 
Figure 3. Cytotoxicity of the FPP. (A) MDCK cells were 
incubated with DMEM containing the FPP at different 
concentrations for 24 hr, and LDH level in the culture medium 
was evaluated.  The value from High Control, incubated with 
NP-40, was set to 100%, and the relative values were plotted. 
Mean values from eight wells are plotted, and the error bars 
indicate standard deviation.  (B) After incubation for 24 hr, 
the cells were treated with MTT for 4 hr, and OD at 570 nm 
was measured after cell lysis.
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tivity.
One possible mechanism underlying the inhibition of 
IFV replication is that the binding of abundant sialic ac-
ids or their analogues in the FPP to the receptor-binding 
pocket of the IFV HA protein causes competition to the 
attachment of the virus to cells.  Alternatively, some 
components of the FPP may bind to IFV particles specifi-
cally and block the infection by IFV.  However, we have 
no evidence to confirm these hypotheses.
Another possibility is the low pH of the FPP.  We 
found that the pH value of 10% FPP is approximately 4 
(data not shown).  The HA protein of an A-type IFV un-
dergoes low-pH-induced conformational change to cause 
membrane fusion in endosomes, which results in the ini-
tiation of virus infection with the assumption that the HA 
protein is activated by limited proteolysis12).  The pH 
threshold is thought to be 5 or 5.5.  The IFV particles 
used in this study had already been activated, and the HA 
proteins might have undergone irreversible conforma-
tional change when exposed to low pH, leading to the loss 
of infectivity.  In contrast, FCV is thought be stable at pH 
5.  Although extremely low pH is known to inactivate 
FCV, the pH for 50% FCV inactivation is approximately 
3.9 (our unpublished observation).
The cytotoxicity of the FPP was examined using two 
methods: LDH leakage to examine membrane integrity 
and MTT test to examine mitochondrial reductase activi-
ty.  The results obtained using both methods showed that 
10% FPP apparently had cytotoxicity.  However, IFV 
could replicate in MDCK cells in the presence of 10% 
FPP, as revealed by the results of the high MOI (=5) ex-
periment. 
In conclusion, the FPP Manda Koso has anti-IFV ac-
tivity and could be beneficial in preventing IFV infection. 
However, because the FPP is not sufficient for use as an 
anti-viral reagent, it is necessary to develop a reagent 
based on the FPP that would be more effective and have 
less cytotoxicity.
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